Pharmacokinetics of Spironolactone After a Single Dose: Evaluation of the true Canrenone Serum Concentrations During 24 Hours
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 5 (2) , 239-248
- https://doi.org/10.3109/10641968309048824
Abstract
In humans spironolactone is metabolized to a large number of metabolites (including canrenone), which are measured by fluorometry. The serum levels of canrenone and other fluorogenic metabolites have been determined by fluorometry in 8 healthy volunteers after administration of a single dose of spironolactone 100 mg. True canrenone levels were measured by a specific HPLC assay. The mean Cmax of true canrenone was only 33% of the Cmax of canrenone + other metabolites. The fraction of true canrenone rises during 24 hours, indicating that canrenone has a slower elimination rate than the other metabolites. The mean of the ratios of the AUC (0-24h) determined by HPLC and the fluoro-metrically determined AUC was 46%. From the literature it is known, that the pharmacological potency of canrenone is only about 1/3 of an equivalent amount of all spironolactone metabolites. From this, combined with our present results, it canKeywords
This publication has 11 references indexed in Scilit:
- Comparison of prorenoate potassium and spironolactone after repeated doses and steady state plasma levels of active metabolites.Published by Wiley ,1982
- Zur Pharmakokinetik von Spironolacton im AlterKlinische Wochenschrift, 1981
- High performance liquid chromatographic method for determination of canrenone in serumJournal of High Resolution Chromatography, 1981
- High-performance liquid chromatographic determination of canrenone, a major metabolite of spironolactone, in body fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Kinetics of canrenone after single and multiple doses of spironolactoneEuropean Journal of Clinical Pharmacology, 1979
- Spironolactone: Diversity in Metabolic PathwaysXenobiotica, 1977
- Spironolactone and potassium canrenoate in normal manClinical Pharmacology & Therapeutics, 1976
- Antagonism of fludrocortisone by spironolactone and canrenone [letter].British Journal of Clinical Pharmacology, 1976
- Spironolactone. I. Disposition and metabolismClinical Pharmacology & Therapeutics, 1976
- Relationship of Plasma Aldadiene Levels and Antimineralocorticoid Effects of Spironolactone in the LaboratoryExperimental Biology and Medicine, 1964